Since admitting they hid previous losses with business acquisitions, Olympus has had to face the reality that they need to pay off previous debts. Reutres is reporting that in order to raise $3.3 billion over the next 3 years, Olympus will need to sell off some of it’s assets. What I didn’t know is that Olympus’ main business is endoscopy related, to which they apparently have a near world wide monopoly. Their camera & microscope divisions on the other hand, operate at a loss. I’m sure many people, investors and camera enthusiasts alike, will be closely watching the news for further developments.
Olympus’ camera division runs at a loss, and it also has businesses in microscopes, the field where it started almost a century ago, industrial testing systems and mobile phones, a small division emerging as a key focus of Japanese authorities investigating the scandal.
Investment bankers say rivals in both endoscopes and cameras are following events at Olympus, though prospective bidders are likely to stay on the sidelines until there is more clarity. – Reutres